The Effects of Pacle Flows on Dialysis in Patients With Acute Decompensated Heart Failure

Pacle flows in 10 milligrams started after we had stabilized patients with acute decompensated heart failure. This resulted in a reduction in mortality by a third and a reduction in readmission for heart failure by about 50%. An anomaly strong result and it's interesting to study was actually stopped early because the sponsor withdrew support And I think after they then published it the sponsor came back like okay We actually like this drug, but they were very compared sglt2 inhibitors or was that considered nothing? No, it's considered placebo.